These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31915990)
121. Repurposing drugs as inhaled therapies in asthma. Anderson SD Adv Drug Deliv Rev; 2018 Aug; 133():19-33. PubMed ID: 29906501 [TBL] [Abstract][Full Text] [Related]
122. Loss of the zona pellucida-binding protein 2 (Zpbp2) gene in mice impacts airway hypersensitivity and lung lipid metabolism in a sex-dependent fashion. Kanagaratham C; Chiwara V; Ho B; Moussette S; Youssef M; Venuto D; Jeannotte L; Bourque G; de Sanctis JB; Radzioch D; Naumova AK Mamm Genome; 2018 Apr; 29(3-4):281-298. PubMed ID: 29536159 [TBL] [Abstract][Full Text] [Related]
123. In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence. Nieto K; Pei P; Wang D; Mallery SR; Schwendeman SP Int J Pharm; 2018 Mar; 538(1-2):48-56. PubMed ID: 29170116 [TBL] [Abstract][Full Text] [Related]
124. Animal models of asthma: utility and limitations. Aun MV; Bonamichi-Santos R; Arantes-Costa FM; Kalil J; Giavina-Bianchi P J Asthma Allergy; 2017; 10():293-301. PubMed ID: 29158683 [TBL] [Abstract][Full Text] [Related]
125. Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside. Garić D; De Sanctis JB; Wojewodka G; Houle D; Cupri S; Abu-Arish A; Hanrahan JW; Hajduch M; Matouk E; Radzioch D J Mol Med (Berl); 2017 Oct; 95(10):1053-1064. PubMed ID: 28695226 [TBL] [Abstract][Full Text] [Related]
126. Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives. Cooper JP; Reynolds CP; Cho H; Kang MH Exp Biol Med (Maywood); 2017 Jun; 242(11):1178-1184. PubMed ID: 28429653 [TBL] [Abstract][Full Text] [Related]
127. Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial. Mohrbacher AM; Yang AS; Groshen S; Kummar S; Gutierrez ME; Kang MH; Tsao-Wei D; Reynolds CP; Newman EM; Maurer BJ Clin Cancer Res; 2017 Aug; 23(16):4550-4555. PubMed ID: 28420721 [No Abstract] [Full Text] [Related]
128. Ceramide channels: destabilization by Bcl-xL and role in apoptosis. Chang KT; Anishkin A; Patwardhan GA; Beverly LJ; Siskind LJ; Colombini M Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2374-84. PubMed ID: 26215742 [TBL] [Abstract][Full Text] [Related]
129. Long-Term Exposure to House Dust Mite Leads to the Suppression of Allergic Airway Disease Despite Persistent Lung Inflammation. Bracken SJ; Adami AJ; Szczepanek SM; Ehsan M; Natarajan P; Guernsey LA; Shahriari N; Rafti E; Matson AP; Schramm CM; Thrall RS Int Arch Allergy Immunol; 2015; 166(4):243-58. PubMed ID: 25924733 [TBL] [Abstract][Full Text] [Related]
130. Translational value of animal models of asthma: Challenges and promises. Sagar S; Akbarshahi H; Uller L Eur J Pharmacol; 2015 Jul; 759():272-7. PubMed ID: 25823808 [TBL] [Abstract][Full Text] [Related]
131. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis. Stiban J; Perera M Biochim Biophys Acta; 2015 Feb; 1848(2):561-7. PubMed ID: 25462172 [TBL] [Abstract][Full Text] [Related]
132. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Engelkes M; Janssens HM; de Jongste JC; Sturkenboom MC; Verhamme KM Eur Respir J; 2015 Feb; 45(2):396-407. PubMed ID: 25323234 [TBL] [Abstract][Full Text] [Related]
133. Pharmacogenomics in asthma therapy: where are we and where do we go? Park HW; Tantisira KG; Weiss ST Annu Rev Pharmacol Toxicol; 2015; 55():129-47. PubMed ID: 25292431 [TBL] [Abstract][Full Text] [Related]
134. Fenretinide prevents inflammation and airway hyperresponsiveness in a mouse model of allergic asthma. Kanagaratham C; Kalivodová A; Najdekr L; Friedecký D; Adam T; Hajduch M; De Sanctis JB; Radzioch D Am J Respir Cell Mol Biol; 2014 Dec; 51(6):783-92. PubMed ID: 24885263 [TBL] [Abstract][Full Text] [Related]
135. Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration. Mata NL; Lichter JB; Vogel R; Han Y; Bui TV; Singerman LJ Retina; 2013 Mar; 33(3):498-507. PubMed ID: 23023528 [TBL] [Abstract][Full Text] [Related]
136. Asthma phenotypes: the evolution from clinical to molecular approaches. Wenzel SE Nat Med; 2012 May; 18(5):716-25. PubMed ID: 22561835 [TBL] [Abstract][Full Text] [Related]
137. Modulation of ceramide synthase activity via dimerization. Laviad EL; Kelly S; Merrill AH; Futerman AH J Biol Chem; 2012 Jun; 287(25):21025-33. PubMed ID: 22539345 [TBL] [Abstract][Full Text] [Related]
138. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Lougheed MD; Lemiere C; Ducharme FM; Licskai C; Dell SD; Rowe BH; Fitzgerald M; Leigh R; Watson W; Boulet LP; Can Respir J; 2012; 19(2):127-64. PubMed ID: 22536582 [TBL] [Abstract][Full Text] [Related]